Cargando…
Cervical cancer therapies: Current challenges and future perspectives
Cervical cancer is the fourth most common female cancer worldwide and results in over 300 000 deaths globally. The causative agent of cervical cancer is persistent infection with high-risk subtypes of the human papillomavirus and the E5, E6 and E7 viral oncoproteins cooperate with host factors to in...
Autores principales: | Burmeister, Carly A., Khan, Saif F., Schäfer, Georgia, Mbatani, Nomonde, Adams, Tracey, Moodley, Jennifer, Prince, Sharon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062473/ https://www.ncbi.nlm.nih.gov/pubmed/35460940 http://dx.doi.org/10.1016/j.tvr.2022.200238 |
Ejemplares similares
-
Point-of-care testing with Xpert HPV for single-visit, screen-and-treat for cervical cancer prevention: a demonstration study in South Africa
por: Denny, Lynette, et al.
Publicado: (2023) -
Assessment of the implementation context in preparation for a clinical study of machine-learning algorithms to automate the classification of digital cervical images for cervical cancer screening in resource-constrained settings
por: Castor, Delivette, et al.
Publicado: (2022) -
Enzyme Therapy: Current Challenges and Future Perspectives
por: de la Fuente, Miguel, et al.
Publicado: (2021) -
Anti-Angiogenic Therapy: Current Challenges and Future Perspectives
por: Lopes-Coelho, Filipa, et al.
Publicado: (2021) -
RNA velocity—current challenges and future perspectives
por: Bergen, Volker, et al.
Publicado: (2021)